Skip to main content
Premium Trial:

Request an Annual Quote

Pfizer and Biogen, Sitting in a Tree ... Well, Maybe

Matthew Herper writes in this article from Forbes that Pfizer, which is already "being name-dropped as a likely buyer" for the recently-on-the-market Biogen, would be making a mistake with such an acquisition. "Merging two pharmaceutical companies can do more harm than good, as a look at Pfizer's stock chart over the last decade shows," according to the article, suggesting that Pfizer's lack of productivity probably stems from a series of mergers that included acquisitions of Warner-Lambert and Pharmacia.

 

The Scan

Pig Organ Transplants Considered

The Wall Street Journal reports that the US Food and Drug Administration may soon allow clinical trials that involve transplanting pig organs into humans.

'Poo-Bank' Proposal

Harvard Medical School researchers suggest people should bank stool samples when they are young to transplant when they later develop age-related diseases.

Spurred to Develop Again

New Scientist reports that researchers may have uncovered why about 60 percent of in vitro fertilization embryos stop developing.

Science Papers Examine Breast Milk Cell Populations, Cerebral Cortex Cellular Diversity, Micronesia Population History

In Science this week: unique cell populations found within breast milk, 100 transcriptionally distinct cell populations uncovered in the cerebral cortex, and more.